Literature DB >> 25011103

Monocyte-plasmablast crosstalk during dengue.

Angela M Green1, Eva Harris2.   

Abstract

Dengue virus infection induces a dramatic expansion of B cell plasmablasts. In this issue, Kwissa et al. (2014) begin with transcriptomic analysis and then integrate studies in human clinical samples, nonhuman primates, and coculture of primary human cells to identify a role for CD14(+)CD16(+) monocytes in generating plasmablast responses during dengue virus infection.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25011103      PMCID： PMC4174296          DOI： 10.1016/j.chom.2014.06.011

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN： 1931-3128            Impact factor:   21.023


  10 in total

1.  Subcapsular sinus macrophages in lymph nodes clear lymph-borne viruses and present them to antiviral B cells.

Authors:  Tobias Junt; E Ashley Moseman; Matteo Iannacone; Steffen Massberg; Philipp A Lang; Marianne Boes; Katja Fink; Sarah E Henrickson; Dmitry M Shayakhmetov; Nelson C Di Paolo; Nico van Rooijen; Thorsten R Mempel; Sean P Whelan; Ulrich H von Andrian
Journal:  Nature       Date:  2007-10-14       Impact factor: 49.962

2.  Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets.

Authors:  Kok Loon Wong; June Jing-Yi Tai; Wing-Cheong Wong; Hao Han; Xiaohui Sem; Wei-Hseun Yeap; Philippe Kourilsky; Siew-Cheng Wong
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

3.  Dengue virus infection induces expansion of a CD14(+)CD16(+) monocyte population that stimulates plasmablast differentiation.

Authors:  Marcin Kwissa; Helder I Nakaya; Nattawat Onlamoon; Jens Wrammert; Francois Villinger; Guey Chuen Perng; Sutee Yoksan; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Rafi Ahmed; Bali Pulendran
Journal:  Cell Host Microbe       Date:  2014-06-26       Impact factor: 21.023

4.  Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans.

Authors:  Jens Wrammert; Nattawat Onlamoon; Rama S Akondy; Guey C Perng; Korakot Polsrila; Anmol Chandele; Marcin Kwissa; Bali Pulendran; Patrick C Wilson; Orasri Wittawatmongkol; Sutee Yoksan; Nasikarn Angkasekwinai; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Rafi Ahmed
Journal:  J Virol       Date:  2012-01-11       Impact factor: 5.103

5.  Patterns of host genome-wide gene transcript abundance in the peripheral blood of patients with acute dengue hemorrhagic fever.

Authors:  Cameron P Simmons; Stephen Popper; Christiane Dolocek; Tran Nguyen Bich Chau; Michael Griffiths; Nguyen Thi Phuong Dung; Truong Hoang Long; Dang Minh Hoang; Nguyen Vinh Chau; Le Thi Thu Thao; Tran Tinh Hien; David A Relman; Jeremy Farrar
Journal:  J Infect Dis       Date:  2007-03-05       Impact factor: 5.226

6.  Phenotyping of peripheral blood mononuclear cells during acute dengue illness demonstrates infection and increased activation of monocytes in severe cases compared to classic dengue fever.

Authors:  Anna P Durbin; Maria José Vargas; Kimberli Wanionek; Samantha N Hammond; Aubree Gordon; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  Virology       Date:  2008-05-02       Impact factor: 3.616

7.  Gene expression patterns of dengue virus-infected children from nicaragua reveal a distinct signature of increased metabolism.

Authors:  P'ng Loke; Samantha N Hammond; Jacqueline M Leung; Charles C Kim; Sajeev Batra; Crisanta Rocha; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2010-06-15

8.  Dominant cross-reactive B cell response during secondary acute dengue virus infection in humans.

Authors:  Simona Zompi; Magelda Montoya; Marie O Pohl; Angel Balmaseda; Eva Harris
Journal:  PLoS Negl Trop Dis       Date:  2012-03-20

9.  Temporal dynamics of the transcriptional response to dengue virus infection in Nicaraguan children.

Authors:  Stephen J Popper; Aubree Gordon; Minghsun Liu; Angel Balmaseda; Eva Harris; David A Relman
Journal:  PLoS Negl Trop Dis       Date:  2012-12-20

10.  Sequential waves of gene expression in patients with clinically defined dengue illnesses reveal subtle disease phases and predict disease severity.

Authors:  Peifang Sun; Josefina García; Guillermo Comach; Maryanne T Vahey; Zhining Wang; Brett M Forshey; Amy C Morrison; Gloria Sierra; Isabel Bazan; Claudio Rocha; Stalin Vilcarromero; Patrick J Blair; Thomas W Scott; Daria E Camacho; Christian F Ockenhouse; Eric S Halsey; Tadeusz J Kochel
Journal:  PLoS Negl Trop Dis       Date:  2013-07-11
  10 in total
  4 in total

1.  CD169 and CD64 could help differentiate bacterial from CoVID-19 or other viral infections in the Emergency Department.

Authors:  Pénélope Bourgoin; Thomas Soliveres; Alexandra Barbaresi; Anderson Loundou; Inès Ait Belkacem; Isabelle Arnoux; Denis Bernot; Marie Loosveld; Pierre-Emmanuel Morange; Pierre Michelet; Fabrice Malergue; Thibaut Markarian
Journal:  Cytometry A       Date:  2021-02-08       Impact factor: 4.714

2.  Distinguishing Incubation and Acute Disease Stages of Mild-to-Moderate COVID-19.

Authors:  Michael Müller; Johann Volzke; Behnam Subin; Christian Johann Schmidt; Hilte Geerdes-Fenge; Emil Christian Reisinger; Brigitte Müller-Hilke
Journal:  Viruses       Date:  2022-01-20       Impact factor: 5.048

3.  A rapid, easy, and scalable whole blood monocyte CD169 assay for outpatient screening during SARS-CoV-2 outbreak, and potentially other emerging disease outbreaks.

Authors:  Moïse Michel; Fabrice Malergue; Inès Ait Belkacem; Pénélope Bourgoin; Pierre-Emmanuel Morange; Isabelle Arnoux; Tewfik Miloud; Matthieu Million; Hervé Tissot-Dupont; Jean-Louis Mege; Joana Vitte; Jean-Marc Busnel
Journal:  SAGE Open Med       Date:  2022-08-03

4.  Single-dose SARS-CoV-2 vaccinations with either BNT162b2 or AZD1222 induce disparate Th1 responses and IgA production.

Authors:  Michael Müller; Johann Volzke; Behnam Subin; Silke Müller; Martina Sombetzki; Emil C Reisinger; Brigitte Müller-Hilke
Journal:  BMC Med       Date:  2022-01-19       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.